Time from Prior Chemotherapy Enhances Prognostic Risk Grouping in the Second-line Setting of Advanced Urothelial Carcinoma: A Retrospective Analysis of Pooled, Prospective Phase 2 Trials

BACKGROUND: Outcomes for patients in the second-line setting of advanced urothelial carcinoma (UC) are dismal. The recognized prognostic factors in this context are Eastern Cooperative Oncology Group (ECOG) performance status (PS) >0, hemoglobin level (Hb) <10 g/dl, and liver metastasis (LM)....

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Sonpavde, Guru, Pond, Gregory R., Fougeray, Ronan, Choueiri, Toni K., Qu, Angela Q., Vaughn, David J., Niegisch, Guenter, Albers, Peter, James, Nicholas D., Wong, Yu-Ning, Ko, Yoo-Joung, Sridhar, Srikala S., Galsky, Matthew D., Petrylak, Daniel P., Vaishampayan, Ulka N., Khan, Awais, Vogelzang, Nicholas J., Beer, Tomasz M., Stadler, Walter M., O’Donnell, Peter H., Sternberg, Cora N., Rosenberg, Jonathan E., Bellmunt, Joaquim
格式: Artigo
語言:Inglês
出版: 2012
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4127896/
https://ncbi.nlm.nih.gov/pubmed/23206856
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2012.11.042
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍